Below is a list of selected peer-reviewed publications. For a complete list, please, refer to Medline.

  1. Zilberberg MD, Shorr AF. Ventilator-associated pneumonia as a model for approaching cost-effectiveness and infection prevention in the ICU. Curr Opin Infect Dis 2011;24:385-9
  2. Zilberberg MD, Shorr AF. Economic aspects of preventing health care-associated infections in the intensive care unit. Crit Care Clinics 2012:28:89-97
  3. Zilberberg MD. Evidence under judgment: can we oversee our own decision-making? Arch Int Med 2011;171:1496-07
  4. Shorr AF, Chan CM, Zilberberg MD. Diagnostics and epidemiology in ventilator-associated pneumonia. Ther Adv Respir Dis. 2011;5:121-30
  5. Zilberberg MD, Tabak YP, Sievert DM, Derby KG, Johannes RS, Sun X, McDonald LC. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Infect Control Hosp Epidemiol 2011;32:649-55
  6. Zilberberg MD. Bayesian thinking: A safer tool for reassurance. Arch Intern Med 2011;171:708
  7. Zilberberg MD. The clinical research enterprise: Time for a course change? JAMA 2011;305:604-5
  8. Zilberberg MD, Chen J, Mody SH, Ramsey AM, Shorr AF. Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm Med 2010 Aug 26;10(1):45.
  9. Zilberberg MD. Understanding cost-effectiveness studies in the ICU. Semin Respir Crit Care Med 2010;31:13-8
  10. Zilberberg MD, Kollef MH, Arnold H, Labelle A, Micek ST, Kothari S, Shorr AF. Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: A retrospective cohort study.  BMC Infect Dis 2010 Jun3;10(1):150
  11. Zilberberg MD, Kothari S, Shorr AF. Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected intensive care unit-acquired candidemia among patients with sepsis: a model simulation. Crit Care 2009 Jun 19;13(3):R94
  12. Zilberberg MD, Mody SH, Chen J, Shorr AF. Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia. Surg Infect (Larchmt) 2010;11:409-17
  13. Shorr AF, Zilberberg MD, Kollef MH. Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2009;30:759-63


Comments are closed.